Kobayashi Pharmaceutical Co. LtdEigentümerstruktur
| Preis (2026-07-17) | 52W Hoch | 52W Tief |
| 28.823 EUR | 31,733 EUR | 26,862 EUR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - EUR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 74.338.764 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Kobayashi Pharmaceutical Co. Ltd
Mitarbeiter 3.731
Handelsplatz F
Ticker Symbol KOY
IPO Datum -
Adresse KDX Kobayashi Doshomachi Building, Osaka, Japan, 541-0045
Webseite https://www.kobayashi.co.jp
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Norikazu Toyoda | President, CEO, Managing Executive Officer, GM of Research & Development and Director |
| 2 | Ms. Yumi Nakagawa | Executive Officer & Chief of Finance |
| 3 | Kenji Kobori | Executive Officer & Head of Sales Headquarters |
| 4 | Atsushi Onoyama | Managing Exec Offc., Head of the Marketing Div & GM of Household Products Glob. Dept - Household Div |
| 5 | Takayuki Kimura | General Manager of General Affairs Department & Human Resources Dept |
| 6 | Mr. Akihiro Kobayashi | Director, Executive Officer & Head of Compensation Response Division |
| 7 | Mr. Fujito Ohwaki | Managing Executive Officer & GM of Healthcare Division |
| 8 | Kei Sato | Executive Officer & Head of Compensation Division |
| 9 | Mr. Keisuke Kajita | Head of Food Section of Health Care Department |
| 10 | Atsushi Uenohara | Corporate Communications Department |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.